Sema4D/CD100 deficiency leads to superior performance in mouse motor behavior

Canadian Journal of Neurological Sciences

Volumn 36, Issue 3, 2009, Pages 349-355

  Yukawa, Kazunori ^a   Tanaka, Tetsuji ^b   Takeuchi, Noriko ^a   Iso, Hiroyuki ^c   Li, Li ^b   Kohsaka, Akira ^b   Waki, Hidefumi ^b   Miyajima, Masayasu ^b   Maeda, Masanobu ^b   Kikutani, Hitoshi ^d   Kumanogoh, Atsushi ^b,d  

^a MEIJO UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG;

ABNORMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MEMORY; MOTOR COORDINATION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ROTAROD TEST; SEMAPHORIN 4D DEFICIENCY; SWIMMING; TASK PERFORMANCE; WILD TYPE;

EID: 67650645733     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100007101     Document Type: Article

References (48)

1. Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins/collapsins. Cell. 1999;97(5):551-2.
2. Kapfhammer JP, Raper JA. Collapse of growth cone structure on contact with specific neurites in culture. J Neurosci. 1987;7(1): 201-12.
3. Nakamura F, Kalb RG, Strittmatter SM. Molecular basis of semaphorin-mediated axon guidance. J Neurobiol. 2000;44(2): 219-29.
4. Raper JA. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol. 2000;10(1):88-94.
5. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005;6(10):789-800.
6. Tamagnone L, Comoglio PM. To move or not to move? Semaphorin signalling in cell migration. EMBO reports. 2004;5(4):356-61.
7. Swiercz JM, Kuner R, Behrens J, Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron. 2002;35(1):51-63.
8. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The semaphorin 4D receptor plexin-B1 is a GTPase activating protein for R-Ras. Science. 2004;305(5685):862-5.
9. Oinuma I, Katoh H, Negishi M. Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating β1 integrin activity. J Cell Biol. 2006;173(4):601-13.
10. Ito Y, Oinuma I, Katoh H, Kaibuchi K, Negishi M. Sema4D/plexin-B1 activates GSK-3β through R-Ras GAP activity, inducing growth cone collapse. EMBO reports. 2006;7(7):704-9.
11. Paradis S, Harrar DB, Lin Y, Koon AC, Hauser JL, Griffith EC, et al. An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. Neuron. 2007;53(2):217-32.
12. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cells activation in CD100-deficient mice. Immunity. 2000;13(5):633-42.
13. Glynn D, Drew CJ, Reim K, Brose N, Morton AJ. Profound ataxia in complexin 1 knockout mice masks a complex phenotype that includes exploratory and habituation deficits. Hum Mol Gent. 2005;14(16):2369-85.
14. Boyce-Rustay JM, Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology. 2006;31(11): 2405-14.
15. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem. 1998;5(4-5):302-16.
16. Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, et al. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem. 2005;280(22):21418-26.
17. Gard PR, Daw P, Mashhour ZS, Tran P. Interactions of angiotensin IV and oxytocin on behaviour in mice. J Renin Angiotensin Aldosterone Syst. 2007;8(3):133-8.
18. Moreau-Fauvarque C, KumanogohA, Camand E, Jaillard C, Barbin G, Boquet I, et al. The transmembrane semaphorin Sema4D/ CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci. 2003;23(27):9229-39.
19. Worzfeld T, Püschel AW, Offermanns S, Kuner R. Plexin-B family members demonstrate non-redundant expression patterns in the developing mouse nervous system: an anatomical basis for morphogenetic effects of Sema4D during development. Euro J Neurosci. 2004;19(40):2622-32.
20. Fazzari P, Penachioni J, Gianola S, Rossi F, Eickholt BJ, Maina F, et al. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev Biol. 2007;7:55.
21. Morris RG. Place navigation impaired in rats with hippocampal lesions. Nature. 1982;297(5868):681-3.
22. Tamagnone L, Comoglio PM. Signaling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 2000;10(9):377-83.
23. Barberis D, Artigiani S, Casazza A, Corso S, Giordano S, Love CA, et al. Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J. 2004;18(3): 592-4.
24. Kumanogoh A, Kikutani H. The CD100-CD72 interaction: a novel mechanism of immune regulation. Trends Immunol. 2001;22 (12):670-6.
25. Furuyama T, Inagaki S, Kosugi A, Noda S, Saitoh S, Ogata M et al. Identification of a novel transmembrane semaphoring expressed on lymphocytes. J Biol Chem. 1996;271(52):33376-81.
26. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A. 2003;100(15):8987-92.
27. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. 2007;54(3):387-402.
28. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology. 2003;28(12):2077-88.
29. Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, Yamamoto M, et al. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int Immunol. 2005;17(10):1277-82.
30. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity; antibody impairs memory. Immunity. 2004;21(2):179-88.
31. Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA. 2006;103(52):19854-9.
32. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543-54.
33. Edwards MJ, Trikouli E, Martino D, Bozi M, Dale RC, Church AJ, et al. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. Neurology. 2004;63 (1):156-8.
34. Fatemi SH. Reelin glycoprotein: structure, biology and roles in health and disease. Mol Psychiatry. 2005;10(3):251-7.
35. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9(7):914-20.
36. Padmos RC, Bekris L, Knijff EM, Tiemeier H, Kupka RW, Cohen D, et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry. 2004;56(7): 476-82.
37. Snider LA, Swedo SE. PANDAS: current status and directions for research. Mol Psychiatry. 2004;9(10):900-7.
38. Ko JA, Kimura Y, Matsuura K, Yamamoto H, Gondo T, Inui M. PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes. J Cell Sci. 2006;119(Pt 24): 5106-13.
39. Wu H, Wang X, Liu S, Wu Y, Zhao T, Chen X, et al. Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur J Cell Biol. 2007;86(6): 331-44.
40. Svensson A, Libelius R, Tågerud S. Semaphorin 6C expression in innervated and denervated skeletal muscle. J Mol Histol. 2008; 39(1):5-13.
41. Whishaw IQ, Suchowersky O, Davis L, Sarna J, Metz GA, Pellis SM. Impairment of pronation, supination, and body coordination in reach-to-grasp tasks in human Parkinson's disease (PD) reveals homology to deficits in animal models. Behav Brain Res. 2002;133(2):165-76.
42. Montoya CP, Campbell-Hope LJ, Pemberton KD, Dunnett SB. The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods. 1991;36(2-3): 219-28.
43. Barnéoud P, Parmentier S, Mazadier M, Miquet JM, Boireau A, Dubédat P, et al. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience. 1995;67(4):837-48.
44. Chang JW, Wachtel SR, Young D, Kang UJ. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience. 1999;88(2):617-28.
45. Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor control. Science. 1994;265(5180):1826-31.
46. Saint-Cyr JA, Taylor AE, Nicholson K. Behavior and the basal ganglia. Adv Neurol. 1995;65:1-28.
47. Ito M. The cerebellum and neural control. New York: Raven Press; 1984.
48. Thach WT, Goodkin HP, Keating JG. The cerebellum and the adaptive coordination of movement. Annu Rev Neurosci. 1992;15:403-42.